Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03580603 · ClinicalTrials.gov registry record · NA
Clinical Decision Support Tools for Antibiotic Prescribing
A NA study of Infectious Disease, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 273
- Enrollment target
- 1
- Study location
NCT03580603: Completed NA study of Infectious Disease, sponsored by Beth Israel Deaconess Medical Center.
NCT03580603 is a NA study of Infectious Disease that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 273 participants, below the 7,010-participant average among 18 other Infectious Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03580603, a NA study of Infectious Disease, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 273 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to assess the utility of a data visualization tool for providers' understanding patients' past microbiological culture sensitivities. Providers that are ordering antibiotics for patients with previous culture data in the medical record will be asked to answer questions regarding past sensitivity results. They will be randomized to either using the visualization tool before answering the questions or using the standard medical record tools. They will then be surveyed about their decision-making, knowledge, and the usefulness of the tool.
Primary Outcome
Provider knowledge of patients' previous culture sensitivity results as determined by the proportion of correct answers on a questionnaire: Do you think this patient has had previous resistance to each of these antibiotics at BIDMC (Beth Israel Deaconess Medical Center)? \[List of the top 4 antibiotic classes to which resistance is seen at BIDMC that the patient has previously had tested for antibiotic sensitivities\] Yes (previous organisms resistant or with intermediate resistance) No (no
Conditions Studied
Interventions
- OTHER Visualization tool
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 2018-03-05 |
| Est. Completion | 2018-09-30 |
| Phase | NA |
What the finished NCT03580603 record still lists
NCT03580603 is an interventional study that assigns participants to a tested intervention. The registered 273 participants enrollment target is mid-sized for trials with a published cap, below the 7,010-participant average among 18 other Infectious Disease trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Infectious Disease appearing as the primary indexed condition, and to 1 intervention - of which Visualization tool is the first listed.
NCT03580603 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03580603 about?
NCT03580603 is a clinical study titled "Clinical Decision Support Tools for Antibiotic Prescribing". The goal of this study is to assess the utility of a data visualization tool for providers' understanding patients' past microbiological culture sensitivities. Providers that are ordering antibiotics for patients with previous culture data in the medical record will be asked to answer questions rega...
What is the current status of trial NCT03580603?
This trial is currently completed. It is a NA study. The enrollment target is 273 participants. The study started on 2018-03-05. Estimated completion is 2018-09-30.
What conditions does trial NCT03580603 study?
This clinical trial studies the following conditions: Infectious Disease.
What interventions are being tested in trial NCT03580603?
The interventions under investigation include: Visualization tool (OTHER).
Who is sponsoring clinical trial NCT03580603?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03580603 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infectious Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03580603's enrollment target sits among peer trials
273 10th of 18 higher than 9 of 18 other Infectious Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infectious Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
RECRUITING · NA
-
Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection
RECRUITING · NA
-
A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor
ACTIVE NOT RECRUITING · NA
-
Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations
ACTIVE NOT RECRUITING · NA
-
Minnesota COVID-19 Testing Project
COMPLETED · NA
-
Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07229430 · 273 participants · NA
Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue
- NCT03808922 · 274 participants · Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- NCT04573504 · 274 participants · Phase 4
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
- NCT05289557 · 274 participants · Phase 3
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI